NCT02292329已完成不适用
Cardiovascular Benefits of Acai in Volunteers at Risk of Metabolic Syndrome.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 23
- 试验地点
- 2
- 主要终点
- Flow-mediated dilation
研究概览
简要总结
The purpose of this study is to carry out a randomized double blind controlled trial in 30 male subjects to investigate the effect of acai consumption on acute changes in vascular function, and to other cardiovascular markers. As a secondary aim the study will allow us to characterize the absorption and metabolism of acai polyphenols in humans over a 24 hour period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 30 Years 至 65 Years（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Male, 30-65 aged, BMI 25-35 kg/m2, Cholesterol <8 mmol/l.
排除标准
- •Female, BMI <25 or >35 kg/m2, Cholesterol >8mmol l-1, elevated fasting blood sugar > 6.5 mmols l-1 , elevated systolic blood pressure >150 mmHg, history of stroke or heart attack within the previous 12 months, current smoking, taking lipid lowering, blood pressure lowering or anti-blood clotting medication or taking micronutrient supplements.
结局指标
主要结局
Flow-mediated dilation
时间窗: Change from baseline to 2h
次要结局
- plasma polyphenol metabolites(Change from baseline to 24h)
研究者
Jeremy Paul Edward Spencer
Professor
University of Reading
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
The Efficacy of Amway Herbal Drink to Improve Skin Anti-agingSkin LaxitySkin LinesNCT05986799Amway (China) R&D Center30
已完成
不适用
Effects of Acleara Needle Insert on AcneAcne VulgarisNCT01677221Theravant Corporation30
终止
4 期
A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS TrialHypogonadismHypogonadism, MaleHypogonadotropic HypogonadismNCT05205837Rigshospitalet, Denmark8
招募中
1 期
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy with AION-301 Administered by Intravenous Infusion Compared with Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age with Chronic Kidney Disease (CKD)Chronic Kidney Disease Stage 3NCT06721143AION Healthspan, Inc.36
已完成
1 期
Phase I Clinical Trial in Healthy Male VolunteersInflammatory Bowel DiseasesNCT03860532Hutchison Medipharma Limited24